Skip to content
healthcare.dev

Alavert Allergy

NDC 80070-110, LORATADINE, tablet, orally disintegrating, from Foundation Consumer Brands.

Product NDC
80070-110
Status
Listed
Labeler
Foundation Consumer Brands
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA021375
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80070-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
Package NDCNDC-11Package
80070-110-188007001101818 BLISTER PACK in 1 CARTON (80070-110-18) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
80070-110-608007001106060 BLISTER PACK in 1 CARTON (80070-110-60) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 80070-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80070-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80070-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.